CM/TNS/24/5713 - NHS Framework for Transition products - 1 February 2025
key details
| Value | £9,867,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | East Midlands, East of England, London, North East, North West, South East, South West, West Midlands, Yorkshire and the Humber |
| Deadline | 18 Nov 2024 |
| Contract start | 1 Feb 2025 |
| Contract end | 31 May 2026 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-e85a5f73-1208-4e45-a159-08011aef8a18 |
Awards (6)
This procurement was awarded to 6 suppliers. Values shown are per-award; the notice total is £9,867,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Baxter Healthcare Ltd shared | £9,867,000 | 14 Jan 2025 | active |
| Biocon shared | £9,867,000 | 14 Jan 2025 | active |
| Dr.Reddy's Laboratories (UK) Limited shared | £9,867,000 | 14 Jan 2025 | active |
| Sun Pharma UK Ltd shared | £9,867,000 | 14 Jan 2025 | active |
| Thornton and Ross Ltd shared | £9,867,000 | 14 Jan 2025 | active |
| Zentiva Pharma UK Ltd shared | £9,867,000 | 14 Jan 2025 | active |
description
Project title: NHS National Framework for Transition products commencing 1 February 2025
Offer reference number: CM/TNS/24/5713
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
Potential periods of call-offs under the framework agreement:
CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection
Lot 1 CESW: 01/02/2025 to 31/05/2026 (16 months)
Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months)
Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 21 Jan 2025 | Award (award) | · | ffeee3ac-9be3-4ea0-8c54-091ab8be7d3f-819135 |
more from NHS England
- Urgent Award - haematological screening · £16,202 · 29 Jul 2026
- HSCN-AWS Connectivity Service for Spine · £228,060 · 29 Jul 2026
- Incentive Voucher Provider · £60,000 · 29 Jul 2026
- CRM for NHSE participant/candidate data 26-27 · £56,640 · 28 Jul 2026
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.